The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

Mamta Parikh, Nataliya V. Uboha, Naoko Takebe, Kit Tam, Philippe L. Bedard, Kari B. Wisinski, Arjun Mittra, Ming Yin, Yuanquan Yang, Anne M. Noonan, Julianne L. Holleran, Christopher Ruel, Paul Frankel, Jan H. Beumer, Edward M. Newman, Alexey V. Danilov, Steven D. Gore, Primo N. Lara

Open source

DOI: 10.1158/2767-9764.crc-25-0305
Published: 2025-11-01
Container: Cancer Research Communications
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-25-0305,
  title = {The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)},
  author = {Mamta Parikh and Nataliya V. Uboha and Naoko Takebe and Kit Tam and Philippe L. Bedard and Kari B. Wisinski and Arjun Mittra and Ming Yin and Yuanquan Yang and Anne M. Noonan and Julianne L. Holleran and Christopher Ruel and Paul Frankel and Jan H. Beumer and Edward M. Newman and Alexey V. Danilov and Steven D. Gore and Primo N. Lara},
  year = {2025},
  journal = {Cancer Research Communications},
  doi = {10.1158/2767-9764.crc-25-0305},
  url = {https://doi.org/10.1158/2767-9764.crc-25-0305}
}

RIS

TY  - JOUR
TI  - The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)
AU  - Mamta Parikh
AU  - Nataliya V. Uboha
AU  - Naoko Takebe
AU  - Kit Tam
AU  - Philippe L. Bedard
AU  - Kari B. Wisinski
AU  - Arjun Mittra
AU  - Ming Yin
AU  - Yuanquan Yang
AU  - Anne M. Noonan
AU  - Julianne L. Holleran
AU  - Christopher Ruel
AU  - Paul Frankel
AU  - Jan H. Beumer
AU  - Edward M. Newman
AU  - Alexey V. Danilov
AU  - Steven D. Gore
AU  - Primo N. Lara
PY  - 2025
JO  - Cancer Research Communications
DO  - 10.1158/2767-9764.crc-25-0305
UR  - https://doi.org/10.1158/2767-9764.crc-25-0305
ER  -

APA

Parikh, M., Uboha, N. V., Takebe, N., Tam, K., Bedard, P. L., Wisinski, K. B., Mittra, A., Yin, M., Yang, Y., Noonan, A. M., Holleran, J. L., Ruel, C., Frankel, P., Beumer, J. H., Newman, E. M., Danilov, A. V., Gore, S. D., & Lara, P. N. (2025). The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404). Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-25-0305

Source records

crossref · retrieved 2026-09-27T14:17:30.119Z